印度血清研究所与 Bavarian Nordic 合作，在全球范围内生产和分销 mpox 疫苗。 Serum Institute of India partners with Bavarian Nordic to produce and distribute mpox vaccine globally.

印度巴伐利亚北欧和血清研究所签署了一项协议,以生产MVA-BN天花疫苗,提高全球制造能力,改善弱势人口获得疫苗的机会。 Bavarian Nordic and Serum Institute of India have signed an agreement to produce MVA-BN® mpox vaccine, increasing global manufacturing capacity and improving access for vulnerable populations. 血清研究所将获得在印度销售和分发疫苗的许可证,经管制批准后可能为巴伐利亚北欧生产疫苗。 Serum Institute will obtain a license to sell and distribute the vaccine in India and may manufacture it for Bavarian Nordic after regulatory approval. 利润分享交易缺乏预付付款,其目的是增加疫苗的供应,特别是在非洲。 The profit-sharing deal lacks upfront payments, aiming to enhance vaccine availability, especially in Africa.